Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
16.82
+0.40 (2.44%)
Nov 5, 2024, 3:49 PM EST - Market open

Tyra Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Selling, General & Admin
20.317.4315.925.652.091.33
Research & Development
75.1562.5243.0120.647.21.79
Operating Expenses
95.4579.9558.9326.299.33.12
Operating Income
-95.45-79.95-58.93-26.29-9.3-3.12
Interest Expense
-----0-0
Interest & Investment Income
14.6110.853.650.01--
Other Non Operating Income (Expenses)
-0.04-0.04-0.05-0.02-0.04-0.94
Pretax Income
-81.44-69.13-55.33-26.29-9.34-4.07
Net Income
-81.44-69.13-55.33-26.29-9.34-4.07
Net Income to Common
-81.44-69.13-55.33-26.29-9.34-4.07
Shares Outstanding (Basic)
4943421423
Shares Outstanding (Diluted)
4943421423
Shares Change (YoY)
16.28%1.96%203.94%793.58%-41.81%-
EPS (Basic)
-1.66-1.62-1.32-1.91-6.05-1.53
EPS (Diluted)
-1.66-1.62-1.32-1.91-6.05-1.53
Free Cash Flow
-64.26-50.91-50.84-24.41-8.08-2.64
Free Cash Flow Per Share
-1.31-1.19-1.21-1.77-5.24-1.00
EBITDA
-95.02-79.59-58.63-26.15-9.25-3.11
D&A For EBITDA
0.430.350.30.140.050.01
EBIT
-95.45-79.95-58.93-26.29-9.3-3.12
Source: S&P Capital IQ. Standard template. Financial Sources.